|
|
|
Insider
Information: |
Adams Brian |
Relationship: |
|
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
451,836 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$2,088,166 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
451,836 |
|
|
Total
Value |
$2,088,166 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
22
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
1
|
21
|
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
Percentage
Gain/Loss : |
-23.6%
|
-723.1%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Keryx Biopharmaceuticals Inc |
KERX |
General Counsel and Se... |
2018-02-15 |
126,069 |
|
0 |
Premium* |
|
Relay Therapeutics, Inc. |
RLAY |
|
2024-04-29 |
325,767 |
2020-07-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
68 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
KERX |
Keryx Biopharmaceuticals ... |
General CounselOfficer |
|
2015-03-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
63,875 |
|
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
53,750 |
106,882 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
48,750 |
141,309 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
General Counsel |
|
2021-03-26 |
4 |
A |
$0.00 |
$0 |
D/D |
15,870 |
25,870 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2022-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
39,270 |
64,917 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
85,425 |
136,956 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
Chief Legal Officer |
|
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
329,667 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-01-15 |
4 |
S |
$3.30 |
$4,363 |
D/D |
(1,322) |
53,132 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2015-10-15 |
4 |
S |
$4.01 |
$4,054 |
D/D |
(1,011) |
57,458 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
General Counsel |
|
2021-01-28 |
4 |
OE |
$4.12 |
$20,600 |
D/D |
5,000 |
15,000 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
General Counsel |
|
2021-04-26 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
32,370 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
General Counsel |
|
2021-06-07 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
32,370 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
General Counsel |
|
2021-09-13 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
32,077 |
0 |
- |
|
RLAY |
Relay Therapeutics, Inc. |
General Counsel |
|
2021-11-15 |
4 |
OE |
$4.12 |
$26,780 |
D/D |
6,500 |
31,784 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-04-05 |
4 |
S |
$4.50 |
$3,416 |
D/D |
(759) |
106,123 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2017-01-30 |
4 |
S |
$4.65 |
$32,476 |
D/D |
(6,984) |
92,559 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2018-01-05 |
4 |
S |
$4.69 |
$3,532 |
D/D |
(753) |
133,262 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-01-06 |
4/A |
S |
$4.70 |
$5 |
D/D |
(1) |
54,454 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2018-01-29 |
4 |
S |
$4.81 |
$7,412 |
D/D |
(1,541) |
131,721 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
General Counsel and Secretary |
|
2018-02-15 |
4 |
S |
$4.81 |
$27,186 |
D/D |
(5,652) |
126,069 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-01-05 |
4/A |
S |
$4.83 |
$14,504 |
D/D |
(3,003) |
54,455 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-10-17 |
4 |
S |
$4.86 |
$5,375 |
D/D |
(1,106) |
101,567 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-04-15 |
4 |
S |
$5.05 |
$5,353 |
D/D |
(1,060) |
105,063 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-01-06 |
4 |
S |
$5.16 |
$15,501 |
D/D |
(3,004) |
54,454 |
0 |
- |
|
KERX |
Keryx Biopharmaceuticals ... |
VP and General Counsel |
|
2016-10-05 |
4 |
S |
$5.38 |
$3,481 |
D/D |
(647) |
102,673 |
0 |
- |
|
68 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|